FDA grants priority review to RBP-6000 NDA, clearance for buprenorphine assay Aug. 1, 2017 No Comments
MMRF selects Avista Pharma to manufacture component of opioid addiction vaccine July 14, 2017 No Comments
Embera NeuroTherapeutics' EMB-001 well tolerated in phase Ib cocaine interaction study May 9, 2017 No Comments
RSS